Table 2.
PMS2/MLH1(-) n=41 | MSH2/MSH6 (-) n=21 | Total n=62 | P value | |
---|---|---|---|---|
Age | ||||
>55 | 27(65.9%) | 15(71.4%) | 42 | 0.657 |
≦55 | 14(34.1%) | 6(28.6%) | 20 | |
Gender | ||||
Male | 18(43.9%) | 10(47.6%) | 28 | 0.993 |
Female | 23(56.1%) | 11(52.4%) | 34 | |
Location | ||||
Left | 8(19.5%) | 4(19.0%) | 12 | 0.639a |
Right | 27(65.9%) | 12(57.1%) | 39 | |
Rectum | 6(14.6%) | 5(23.8%) | 11 | |
Diameter | ||||
≦5 cm | 19(46.3%) | 8(38.1%) | 27 | 0.535 |
>5 cm | 22(53.7%) | 13(61.9%) | 35 | |
Lymphovascular invasion | ||||
Absent | 27(65.9%) | 16(76.2%) | 43 | 0.403 |
Present | 14(34.1%) | 5(23.8%) | 19 | |
Extranodal extension | ||||
Absent | 37(90.2%) | 20(95.2%) | 57 | 0.849 |
Present | 4(9.8%) | 1(4.8%) | 5 | |
T stage | ||||
T1-3 | 16(39.0%) | 7(33.3%) | 23 | 0.872 |
T4 | 25(61.0%) | 14(66.7%) | 39 | |
N stage | ||||
N0 | 27(65.9%) | 17(81.0%) | 44 | 0.584a |
N1 | 11(26.8%) | 3(14.3%) | 14 | |
N2 | 3(7.3%) | 1(4.8%) | 4 | |
TNM stage | ||||
I | 5(12.2%) | 4(19.0%) | 9 | 0.420a |
II | 22(53.7%) | 13(61.9%) | 35 | |
III | 14(34.1%) | 4(19.0%) | 18 | |
Tumor grade | ||||
I | 4(9.8%) | 1(4.8%) | 5 | 0.925a |
II | 20(48.8%) | 11(52.4%) | 31 | |
III | 17(41.5%) | 9(42.9%) | 26 | |
Tumor type | ||||
NOS | 32(78.0%) | 15(71.4%) | 47 | 0.781a |
Medullary | 2(4.9%) | 1(4.8%) | 3 | |
Mucinous | 7(17.1%) | 5(23.8%) | 12 |
Note: aFisher’s exact test.